Supernus Pharmaceuticals, Inc. (SUPN)
48.35
-1.08
(-2.18%)
USD |
NASDAQ |
May 18, 16:00
47.86
-0.49
(-1.01%)
After-Hours: 16:46
Supernus Pharmaceuticals Shareholders Equity (Quarterly) : 1.077B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 637.99M |
| Johnson & Johnson | 81.19B |
| Amphastar Pharmaceuticals, Inc. | 773.39M |
| Assertio Holdings, Inc. | 75.63M |
| Eli Lilly & Co. | 31.20B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.501B |
| Total Liabilities (Quarterly) | 423.92M |
| Debt to Equity Ratio | 0.038 |
| Current Ratio | 1.956 |
| Net Debt Paydown Yield | -0.04% |